EBS — Emergent BioSolutions Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1367644 ·
Last close
$6.86
Market Cap
$351.74M
52W High
$14.06
52W Low
$4.36
ADV30
1,173,856
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 226,800,000 | 129,700,000 | 66,200,000 | -180,200,000 | 1,116,800,000 | 139,700,000 | 775,400,000 |
| Mar 2026 | 149,700,000 | 77,700,000 | 10,500,000 | 6,800,000 | 1,320,400,000 | 160,300,000 | 797,300,000 |
| Dec 2025 | 143,800,000 | 58,900,000 | -15,700,000 | -54,600,000 | 1,318,600,000 | 205,400,000 | 796,000,000 |
| Sep 2025 | 222,000,000 | 136,100,000 | 76,500,000 | 51,200,000 | 1,461,000,000 | 245,500,000 | 878,500,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$148,000,000
Investing CF
$7,500,000
Financing CF
$-147,600,000
CapEx
$-12,600,000
Dividends Paid
—
Buybacks
$-33,900,000
EPS Diluted TTM
$-0.28
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-333,200,000
Inventory
$303,600,000
Receivables
$190,000,000
ST Investments
—
EBIT TTM
$-95,100,000
Pretax Income TTM
$-146,000,000
Interest Exp TTM
$50,900,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$770,200,000
EBITDA
$232,400,000
Free Cash Flow
$37,500,000
Enterprise Value
$767,932,864
Total Cash
$139,700,000
Total Debt
$588,200,000
Shares Out
51,273,336
Trailing EPS
$-3.41
Book Value
$6.66
ROE
-40.3%
ROA
6.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 705,200,000 | 112,300,000 | 52,600,000 | 1,318,600,000 | 796,000,000 | 522,600,000 | 170,600,000 |
| Dec 2024 | 1,013,600,000 | -81,500,000 | -190,600,000 | 1,389,700,000 | 906,900,000 | 482,800,000 | 58,700,000 |
| Dec 2023 | 1,023,000,000 | -201,500,000 | -760,500,000 | 1,823,200,000 | 1,173,900,000 | 649,300,000 | -206,300,000 |
| Dec 2022 | 1,076,100,000 | -163,300,000 | -211,600,000 | 3,166,300,000 | 1,778,600,000 | 1,387,700,000 | -34,100,000 |
TTM Snapshot
Revenues TTM
$1,029,200,000
NetIncome TTM
$-137,000,000
OpCashFlow TTM
$0
Assets (Latest)
$1,318,600,000
Forward EPS
$1.05
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $8.00 · spot: $6.86 · call volume: 108 · put volume: 193
Expected Move to 2027-01-15:
±$2.25
(32.80%) —
implied range
$4.61 –
$9.11
· ATM straddle on $7.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | $356.70M | $3.31 | — |
| PRE | Prenetics Global Ltd | $345.92M | $22.76 | — |
| BNTC | Benitec Biopharma Inc. | $344.23M | $10.02 | — |
| ENTA | ENANTA PHARMACEUTICALS INC | $367.42M | $12.61 | — |
| BIOA | BioAge Labs, Inc. | $329.54M | $7.18 | — |
News headlines (Yahoo Finance, 1h cache)
Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility
2026-09-15 11:45 · Yahoo
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
2026-09-07 11:02 · Yahoo
Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes
2026-09-03 11:45 · Yahoo
Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray
2026-08-31 11:55 · Yahoo
Emergent BioSolutions (EBS) Q2 2026 Earnings Call Transcript
2026-08-12 22:13 · Yahoo
Emergent Biosolutions Q2 Earnings Call Highlights
2026-08-08 05:03 · Yahoo
Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment
2026-08-05 20:07 · Yahoo
Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026
2026-07-22 20:01 · Yahoo
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
2026-06-29 13:13 · Yahoo
Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
2026-06-04 12:02 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.